900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	est un(e) (attribut)	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Hydromorphone hydrochloride 1mg/mL injection solution ampule (product)	Hydromorphone hydrochloride 1 mg/mL solution for injection
Hydromorphone hydrochloride 32mg m/r capsule (product)	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 32mg prolonged-release oral capsule (product)	Product containing only hydromorphone in oral dose form (medicinal product form)
Hydromorphone hydrochloride 4mg/mL injection solution ampule (product)	Hydromorphone hydrochloride 4 mg/mL solution for injection
Hydrous wool fat+zinc oxide 4/8% conventional release cutaneous cream (product)	Lanolin and zinc oxide only product in cutaneous dose form
Hydrous wool fat+zinc oxide 4/8% cream (product)	Lanolin and zinc oxide only product in cutaneous dose form
Hydroxocobalamin 1mg/mL injection 1mL ampule	Product containing precisely hydroxocobalamin (as hydroxocobalamin acetate) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Hydroxocobalamin 2.5g powder for conventional release solution for injection vial	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxocobalamin 2.5g powder for injection solution vial + diluent (product)	Product containing only hydroxocobalamin in parenteral dose form (medicinal product form)
Hydroxyethylcellulose 0.44% conventional release eye drops	Product containing only hyetellose (medicinal product)
Hydroxyethylcellulose 0.44% single-use eye drops (product)	Product containing only hyetellose (medicinal product)
Hydroxypropyl methylcellulose 0.32% conventional release eye drops (product)	Hypromellose 3.2 mg/mL eye solution
Hydroxypropyl methylcellulose 0.32% single-use eye drops	Hypromellose 3.2 mg/mL eye solution
Hydroxypropylmethylcellulose 2% eye drops (product)	Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug)
Hyoscine butylbromide allergy	Allergy to hyoscine
Hyoscine hydrobromide 0.125% eye drops (product)	Scopolamine (as scopolamine hydrobromide) 1.25 mg/mL eye solution
Hyoscine hydrobromide 0.25% eye drops (product)	Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug)
Hyoscine hydrobromide 0.5% eye drops (product)	Product containing precisely scopolamine (as scopolamine hydrobromide) 5 milligram/1 milliliter conventional release eye solution (clinical drug)
Hyoscine hydrobromide allergy	Allergy to hyoscine
Hyoscyamine sulfate 0.031mg/1 mL (product)	Hyoscyamine only product
Hyoscyamine sulfate 0.125mg/5mL elixir (product)	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/5mL liquid (product)	Hyoscyamine sulfate 25 microgram/mL oral solution
Hyoscyamine sulfate 0.125mg/mL liquid (product)	Hyoscyamine sulfate 25 microgram/mL oral solution
HyperHEP B S/D 217 international units per milliliter solution for injection Grifols Canada Limited (product)	HyperHEP B S/D 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug)
Hyperalphaglobulinemia	Hyperalphaglobulinaemia
Hyperbetaglobulinemia	Hyperbetaglobulinemia
Hyperchromia	Hyperchromatism
Hypercupremia (disorder)	Raised blood copper level (finding)
Hypercupremia	Raised blood copper level (finding)
Hyperglobulinemia	Hyperglobulinemia
Hyperglycemia clinical management plan (qualifier value)	Hyperglycemia clinical management plan
Hyperglycemia self management plan (qualifier value)	Hyperglycemia self management plan
hyperhidrose, caries prématurées et aplasie des prémolaires	Book syndrome (disorder)
Hyperlipidemia clinical management plan	Hyperlipidaemia clinical management plan
Hypermenorrhea	ménorragie
Hypermobility	hypermobilité de l'appareil locomoteur
Hyperpyrexia	Hyperpyrexia (finding)
Hypertension clinical management plan (qualifier value)	Hypertension clinical management plan (record artifact)
Hypertensive ischemic ulcer	Ulcer of skin caused by ischemia due to hypertensive disease (disorder)
Hyperthermia in newborn, unspecified	Hyperthermia in newborn
Hypertonic saline (product)	Sodium chloride only product
Hypertrichosis universalis	Congenital hypertrichosis (disorder)
Hypertrophic cardiomyopathy associated with another disorder (disorder)	Hypertrophic cardiomyopathy due to disorder
Hypertrophic cardiomyopathy secondary to Friedreich's ataxia (disorder)	Hypertrophic cardiomyopathy due to Friedreich ataxia
Hypertrophic cardiomyopathy secondary to hyperthyroidism	Hypertrophic cardiomyopathy due to hyperthyroidism
Hypertrophic cardiomyopathy secondary to neuromuscular disorder	Hypertrophic cardiomyopathy due to neuromuscular disorder
Hypertrophy of bone	External hyperostosis
Hypertrophy of bone and cartilage	External hyperostosis
Hypertrophy of cartilage	hypertrophie
Hypnotic dependence with current use (disorder)	Hypnotic dependence (disorder)
Hypoactive sexual desire disorder	manque ou perte de désir sexuel
Hypoalphaglobulinemia	hypo-alpha-globulinémie
Hypobetaglobulinemia	hypo-alpha-globulinémie
Hypoglobulinemia	Hypoglobulinaemia
Hypoglycemia clinical management plan (qualifier value)	Hypoglycemia clinical management plan (record artifact)
Hypoglycemia self management plan (qualifier value)	Hypoglycaemia self management plan
Hypoparathyroidism - autosomal dominant	Autosomal dominant familial isolated hypoparathyroidism (disorder)
Hypopharyngeal TNM finding (finding)	American Joint Committee on Cancer allowable value
Hypophysectomy by other specified approach (procedure)	Hypophysectomy (procedure)
Hyposensitivity	Hyposensitivity
Hypospadias, balanic	Glanular hypospadias
Hypospadias, hypertelorism, coloboma, deafness syndrome (disorder)	BSG syndrome
Hypothyroidism clinical management plan (qualifier value)	Hypothyroidism clinical management plan
Hypotonic artificial tears eye drops (product)	Medicinal product categorised by therapeutic role
Hypromellose eye drops allergy	Allergy to hypromellose
Ibandronic acid 1mg/mL injection solution 2mL vial (product)	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL injection solution 3mL prefilled syringe (product)	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL injection solution 6mL vial (product)	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL intravenous infusion conc (product)	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibandronic acid 1mg/mL intravenous infusion conc (product)	Product containing precisely ibandronic acid (as ibandronate sodium) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)
Ibuprofen 40mg/mL oral drops (product)	Ibuprofen 40 mg/mL oral suspension
Ibuprofen+pseudoephedrine 100mg/15mg oral 5mL suspension (product)	Product containing precisely ibuprofen 20 milligram/1 milliliter and pseudoephedrine hydrochloride 3 milligram/1 milliliter conventional release oral suspension (clinical drug)
Ichthyobodo nector	Ichthyobodo necator (organism)
Icodextrin 7.5% peritoneal dialysis solution (product)	Icodextrin only product
Idiopathic benign cutaneous mucinosis	Localized lichen myxedematosus
Idiopathic interstitial pneumonia	Idiopathic pulmonary fibrosis (disorder)
Idiopathic hypertrophic subaortic stenosis	cardiomyopathie obstructive hypertrophique (trouble)
Idiopathic hypertrophic subaortic stenosis	cardiomyopathie obstructive hypertrophique (trouble)
Idiopathic multifocal fibrosclerosis, NEC	Multifocal fibrosclerosis
Idiopathic proctocolitis	Proctocolitis (disorder)
Idiopathic purpura (& thrombocytopenic) (disorder)	Immune thrombocytopenia
Idiopathic respiratory distress syndrome (disorder)	syndrome de détresse respiratoire du nouveau-né (trouble)
Idiopathic retroperitoneal fibrosis (disorder)	fibrose rétropéritonéale
Idiopathic thrombocythemia	Essential thrombocythemia
Idiopathic tomboyishness	Gender identity finding
Idiosyncratic intoxication	Aggression caused by ethanol (finding)
Idoxuridine 0.1% (product)	Idoxuridine 1 mg/mL eye solution
Iliofemoral vascular bypass (procedure)	Iliofemoral shunt (procedure)
Illegal termination of pregnancy, complete	Induced termination of pregnancy (procedure)
Illegal abortion complicated by cardiac arrest (disorder)	Induced termination of pregnancy complicated by cardiac arrest
Illegal abortion complicated by cardiac failure (disorder)	Induced termination of pregnancy complicated by cardiac failure
Illegal termination of pregnancy complicated by damage to pelvic organs and/or tissues	Induced termination of pregnancy complicated by damage to pelvic organs and/or tissues (disorder)
Illegal termination of pregnancy complicated by delayed and/or excessive hemorrhage	Excessive hemorrhage due to and following induced termination of pregnancy (disorder)
Illegal termination of pregnancy complicated by embolism	Induced termination of pregnancy complicated by embolism (disorder)
Illegal abortion complicated by genital-pelvic infection (disorder)	Induced termination of pregnancy complicated by genital-pelvic infection (disorder)
Illegal abortion complicated by genital-pelvic infection	Induced termination of pregnancy complicated by genital-pelvic infection (disorder)
Illegal termination of pregnancy complicated by metabolic disorder	Induced termination of pregnancy complicated by metabolic disorder (disorder)
Illegal termination of pregnancy complicated by renal failure	Induced termination of pregnancy complicated by renal failure (disorder)
avortement illégal compliqué de choc	Induced termination of pregnancy complicated by shock
Illegal termination of pregnancy, incomplete	Incomplete induced termination of pregnancy
Illegal abortion unspecified	Induced termination of pregnancy (procedure)

Start Previous Page 46 of 132 Next End

Reference Sets

Canada French language reference set (foundation metadata concept)

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)